Europe Active Pharmaceutical Ingredients (API) Market Size, Share & Trends Analysis Report By Type Of Synthesis, By Type Of Manufacturer (Captive), By Type (Generic), By Application, By Type Of Drug, By Country, And Segment Forecast, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                  1.1 Market Segmentation and Scope
                      1.1.1 Regional scope
                      1.1.2 Estimates and forecast timeline
                  1.2 Research Methodology
                  1.3 Information procurement
                      1.3.1 Purchased database:
                      1.3.2 GVR’s internal database
                      1.3.3 Secondary sources
                      1.3.4 Primary research
                  1.4 Information or Data Analysis
                      1.4.1 Data analysis models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity Flow Analysis (Model 1)
                      1.6.1.1 Approach 1: Commodity Flow Approach
                  1.7 Research Assumptions
                  1.8 Key KoL Responses
                  1.9 Market share calculations
                  1.10 List of Secondary Sources
                  1.11 List of Abbreviations
                  1.12 Objectives
                      1.12.1 Objective 1
                      1.12.2 Objective 2
                      1.12.3 Objective 3
                      1.12.4 Objective 4
Chapter 2 Europe Active Pharmaceutical Ingredients Market: Executive Summary
                  2.1 Segment Outlook
                  2.2 Competitive Outlook
                  2.3 Market Outlook
Chapter 3 Europe Active Pharmaceutical Ingredients Market Variables, Trends, and Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent market outlook
                  3.2 Penetration and Growth Prospect Mapping
                  3.3 User Perspective Analysis
                  3.4 Market Dynamics
                      3.4.1 Market Driver Analysis
                          3.4.1.1 Growing geriatric population
                          3.4.1.2 Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
                          3.4.1.3 Increasing preference for targeted therapy approach in cancer treatment
                          3.4.1.4 Increasing preference for outsourcing APIs
                      3.4.2 Market Restraint Analysis
                          3.4.2.1 High capital investments and production cost
                          3.4.2.2 Stringent Safety and handling regulations regarding APIs
                  3.5 Market Analysis Tools
                      3.5.1 Industry Analysis: Porter’s
                      3.5.2 PESTLE Analysis
                      3.5.3 Regulatory Scenario
Chapter 4 Europe Active Pharmaceutical Ingredients Market: Competitive Analysis
                  4.1 Recent Developments & Impact Analysis, by Key Market Participants
                      4.1.1 Ansoff matrix
                      4.1.2 Heat map analysis
                  4.2 Company Categorization
                      4.2.1 Innovators
                      4.2.2 Market Leaders
                  4.3 Vendor Landscape
                      4.3.1 List of key distributors and channel partners
                      4.3.2 Key customers
                      4.3.3 Key company market share analysis, 2022
                  4.4 Public Companies
                      4.4.1 Company market position analysis
                      4.4.2 Company market position analysis
                      4.4.3 Competitive Dashboard Analysis
                          4.4.3.1 Market Differentiators
                  4.5 Private Companies
                      4.5.1 List of key emerging companies
                  4.6 Major Deals and Strategic Alliances Analysis
                      4.6.1 Joint Ventures
                      4.6.2 Acquisitions
                      4.6.3 Licensing and Partnerships
                      4.6.4 Technological Collaborations
Chapter 5 Europe Active Pharmaceutical Ingredients Molecules Outlook
                  5.1 European Sales of API Molecules, USD Million, 2018 - 2022
                  5.2 Companies with the leading market position for API molecules
                      5.2.1 Amoxicillin
                      5.2.2 Azithromycin
                      5.2.3 Bleomycin
                      5.2.4 Caspofungin
                      5.2.5 Clarithromycin
                      5.2.6 Clavulanic acid
                      5.2.7 Clindamycin
                      5.2.8 Compactin (Mevastatin)
                      5.2.9 Cyclosporin
                      5.2.10 Dactinomycin
                      5.2.11 Daptomycin
                      5.2.12 Demeclocycline
                      5.2.13 Doxycycline
                      5.2.14 Erythromycin
                      5.2.15 Ivermectin (Avermectin)
                      5.2.16 Lovastatin
                      5.2.17 Micafungin
                      5.2.18 Minocycline
                      5.2.19 Mitomycin
                      5.2.20 Mycophenolic acid
                      5.2.21 Pneumocandin B0
                      5.2.22 Polymyxin
                      5.2.23 Pravastatin
                      5.2.24 Rapamycin (Sirolimus)
                      5.2.25 Simvastatin
                      5.2.26 Steroids
                      5.2.27 Tacrolimus
                      5.2.28 Tetracycline
                      5.2.29 Tigecycline
                      5.2.30 Tobramycin
                      5.2.31 Vancomycin
Chapter 6 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Type of Synthesis, 2018 - 2030 (USD Billion)
                  6.1 Definition and Scope
                  6.2 Type of Synthesis Market Share Analysis, 2022 & 2030
                  6.3 Segment Dashboard
                  6.4 Europe API Market, by Type of Synthesis, 2018 to 2030
                  6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                      6.5.1 Biotech API
                          6.5.1.1 Biotech API market, 2018 - 2030 (USD Billion)
                          6.5.1.2 Biotech API market, By type, 2018 - 2030 (USD Billion)
                          6.5.1.3 Generic API
                              6.5.1.3.1 Generic API market, 2018 - 2030 (USD Billion)
                          6.5.1.4 Innovative API
                              6.5.1.4.1 Innovative APIs market, 2018 - 2030 (USD Billion)
                          6.5.1.5 Biotech APIs market, By product (Revenue, USD Billion, 2018 - 2030)
                          6.5.1.6 Monoclonal Antibodies
                              6.5.1.6.1 Monoclonal antibodies market, 2018 - 2030 (USD Billion)
                          6.5.1.7 Hormones
                              6.5.1.7.1 Hormones market, 2018 - 2030 (USD Billion)
                          6.5.1.8 Cytokines
                              6.5.1.8.1 Cytokines market, 2018 - 2030 (USD Billion)
                          6.5.1.9 Recombinant Proteins
                              6.5.1.9.1 Recombinant proteins market, 2018 - 2030 (USD Billion)
                          6.5.1.10 Therapeutic Enzymes
                              6.5.1.10.1 Therapeutic enzymes market, 2018 - 2030 (USD Billion)
                          6.5.1.11 Vaccines
                              6.5.1.11.1 Vaccines market, 2018 - 2030 (USD Billion)
                          6.5.1.12 Blood Factors
                              6.5.1.12.1 Blood factors market, 2018 - 2030 (USD Billion)
                      6.5.2 Synthetic API
                          6.5.2.1 Synthetic API market, 2018 - 2030 (USD Billion)
                          6.5.2.2 Synthetic API market, By type (Revenue, USD Billion, 2018 - 2030)
                          6.5.2.3 Generic API
                              6.5.2.3.1 Generic API market, 2018 - 2030 (USD Billion)
                          6.5.2.4 Innovative API
                              6.5.2.4.1 Innovative API market, 2018 - 2030 (USD Billion)
Chapter 7 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Type of Manufacturer, 2018 - 2030 (USD Billion)
                  7.1 Definition and Scope
                  7.2 Type of Manufacturer Market Share Analysis, 2022 & 2030
                  7.3 Segment Dashboard
                  7.4 Europe API Market, by Type of Manufacturers, 2018 to 2030
                  7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                      7.5.1 Captive API
                          7.5.1.1 Captive API market, 2018 - 2030 (USD Billion)
                      7.5.2 Merchant API
                          7.5.2.1 Captive API market, 2018 - 2030 (USD Billion)
                          7.5.2.2 Merchant APIs market, By type (Revenue, USD Billion, 2018 - 2030)
                          7.5.2.3 Generic API
                              7.5.2.3.1 Generic APIs market, 2018 - 2030 (USD Billion)
                          7.5.2.4 Innovative API
                              7.5.2.4.1 Innovative APIs market, 2018 - 2030 (USD Billion)
                          7.5.2.5 Merchant API market, By type of synthesis (Revenue, USD Billion, 2018 - 2030)
                          7.5.2.6 Biotech
                              7.5.2.6.1 Biotech market, 2018 - 2030 (USD Billion)
                          7.5.2.7 Synthetic
                              7.5.2.7.1 Synthetic market, 2018 - 2030 (USD Billion)
Chapter 8 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Type, 2018 - 2030 (USD Billion)
                  8.1 Definition and Scope
                  8.2 Type Market Share Analysis, 2022 & 2030
                  8.3 Segment Dashboard
                  8.4 Europe API Market, by Type, 2018 to 2030
                  8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                      8.5.1 Generic API
                          8.5.1.1 Generic API market, 2018 - 2030 (USD Billion)
                      8.5.2 Innovative API
                          8.5.2.1 Innovative API market, 2018 - 2030 (USD Billion)
Chapter 9 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Application, 2018 - 2030 (USD Billion)
                  9.1 Definition and Scope
                  9.2 Application Market Share Analysis, 2022 & 2030
                  9.3 Segment Dashboard
                  9.4 Europe API Market, by Application, 2018 to 2030
                  9.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                      9.5.1 Cardiovascular Diseases
                          9.5.1.1 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
                      9.5.2 Oncology
                          9.5.2.1 Oncology market, 2018 - 2030 (USD Billion)
                      9.5.3 CNS and Neurology
                          9.5.3.1 CNS and neurology market, 2018 - 2030 (USD Billion)
                      9.5.4 Orthopedics
                          9.5.4.1 Orthopedics market, 2018 - 2030 (USD Billion)
                      9.5.5 Endocrinology
                          9.5.5.1 Endocrinology market, 2018 - 2030 (USD Billion)
                      9.5.6 Pulmonology
                          9.5.6.1 Pulmonology market, 2018 - 2030 (USD Billion)
                      9.5.7 Gastroenterology
                          9.5.7.1 Gastroenterology market, 2018 - 2030 (USD Billion)
                      9.5.8 Nephrology
                          9.5.8.1 Nephrology market, 2018 - 2030 (USD Billion)
                      9.5.9 Ophthalmology
                          9.5.9.1 Ophthalmology market, 2018 - 2030 (USD Billion)
                      9.5.10 Others
                          9.5.10.1 Others market, 2018 - 2030 (USD Billion)
Chapter 10 Europe Active Pharmaceutical Ingredients Market: Segment Analysis, by Type of Drug, 2018 - 2030 (USD Billion)
                  10.1 Definition and Scope
                  10.2 Type of Drug Market Share Analysis, 2022 & 2030
                  10.3 Segment Dashboard
                  10.4 Europe API Market, by Type of Drug, 2018 to 2030
                  10.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                      10.5.1 Prescription
                          10.5.1.1 Prescription market, 2018 - 2030 (USD Billion)
                      10.5.2 OTC
                          10.5.2.1 OTC market, 2018 - 2030 (USD Billion)
Chapter 11 Europe Active Pharmaceutical Ingredients Market: Country Market Analysis, 2018 - 2030 (USD Billion)
                  11.1 Definition & Scope
                  11.2 Country Market Share Analysis, 2022 & 2030
                  11.3 Country Market Dashboard
                  11.4 Country Market Snapshot
                  11.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
                  11.6 Europe
                      11.6.1 Europe API market, 2018 - 2030 (USD Billion)
                      11.6.2 UK
                          11.6.2.1 U.K. API market, 2018 - 2030 (USD Billion)
                      11.6.3 Germany
                          11.6.3.1 Germany API market, 2018 - 2030 (USD Billion)
                      11.6.4 Spain
                          11.6.4.1 Spain API market, 2018 - 2030 (USD Billion)
                      11.6.5 France
                          11.6.5.1 France API market, 2018 - 2030 (USD Billion)
                      11.6.6 Italy
                          11.6.6.1 Italy API market, 2018 - 2030 (USD Billion)
                      11.6.7 Russia
                          11.6.7.1 Russia API market, 2018 - 2030 (USD Billion)
                      11.6.8 Hungary
                          11.6.8.1 Hungary API market, 2018 - 2030 (USD Billion)
                      11.6.9 Poland
                          11.6.9.1 Poland API market, 2018 - 2030 (USD Billion)
                      11.6.10 Switzerland
                          11.6.10.1 Switzerland API market, 2018 - 2030 (USD Billion)
                      11.6.11 Sweden
                          11.6.11.1 Sweden API market, 2018 - 2030 (USD Billion)
Chapter 12 Europe Active Pharmaceutical Ingredients: Company Profiles
                  12.1 Merck & Co., Inc.
                      12.1.1 Company overview
                      12.1.2 Financial performance
                      12.1.3 Product benchmarking
                      12.1.4 Strategic initiatives
                  12.2 Boehringer Ingelheim International GmbH
                      12.2.1 Company overview
                      12.2.2 Financial performance
                      12.2.3 Product benchmarking
                      12.2.4 Strategic initiatives
                  12.3 Bristol-Myers Squibb Company
                      12.3.1 Company overview
                      12.3.2 Financial performance
                      12.3.3 Product benchmarking
                      12.3.4 Strategic initiatives
                  12.4 Cipla, Inc.
                      12.4.1 Company overview
                      12.4.2 Financial performance
                      12.4.3 Product benchmarking
                      12.4.4 Strategic initiatives
                  12.5 AbbVie, Inc.
                      12.5.1 Company overview
                      12.5.2 Financial performance
                      12.5.3 Product benchmarking
                      12.5.4 Strategic initiatives
                  12.6 Albemarle Corporation
                      12.6.1 Company overview
                      12.6.2 Financial performance
                      12.6.3 Product benchmarking
                  12.7 Aurobindo Pharma
                      12.7.1 Company overview
                      12.7.2 Financial performance
                      12.7.3 Product benchmarking
                      12.7.4 Strategic initiatives
                  12.8 Viatris Inc. (Mylan N.V.)
                      12.8.1 Company overview
                      12.8.2 Financial performance
                      12.8.3 Product benchmarking
                      12.8.4 Strategic initiatives
                  12.9 Teva Pharmaceutical Industries Ltd.
                      12.9.1 Company overview
                      12.9.2 Financial performance
                      12.9.3 Product benchmarking
                      12.9.4 Strategic initiatives
                  12.10 Sun Pharmaceutical Industries Ltd.
                      12.10.1 Company overview
                      12.10.2 Financial performance
                      12.10.3 Product benchmarking
                      12.10.4 Strategic initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Europe Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
TABLE 5 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 6 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 7 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 8 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 22 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
TABLE 23 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 24 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 25 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 26 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 27 U.K. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 28 U.K. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 29 U.K. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 30 U.K. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 31 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 32 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 33 Germany America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 34 Germany America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 35 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 36 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 37 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 38 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 39 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 40 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 41 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 42 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 43 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 44 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 45 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 46 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 47 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 48 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 49 Russia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 50 Russia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 51 Switzerland Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 52 Switzerland Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 53 Switzerland Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 54 Switzerland Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 55 Poland Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 56 Poland Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 57 Poland Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 58 Poland Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 59 Hungary Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 60 Hungary Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 61 Hungary Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 62 Hungary Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 63 PortugalActive Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 64 Portugal Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 65 Portugal Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 66 Portugal Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
TABLE 67 Sweden Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
TABLE 68 Sweden Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
TABLE 69 Sweden Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
TABLE 70 Sweden Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion) 

List of Figures

FIG. 1 Europe active pharmaceutical ingredients market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Europe API market, segment outlook
FIG. 10 Europe API market, competitive outlook
FIG. 11 Europe API market outlook (2021)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 User perspective analysis
FIG. 14 Market driver relevance analysis (Current & future impact)
FIG. 15 Global percentage of the population, by age group, 2050 and 2000
FIG. 16 Market restraint relevance analysis (Current & future impact)
FIG. 17 Porter’s five forces analysis
FIG. 18 PESTLE analysis
FIG. 19 Ansoff Matrix
FIG. 20 Heat map analysis
FIG. 21 Company market position analysis
FIG. 22 Company market position analysis
FIG. 23 Market differentiators
FIG. 24 Strategy mapping
FIG. 25 Europe API market: Type of Synthesis movement analysis
FIG. 26 Segment dashboard
FIG. 27 Europe API market type of synthesis outlook: Key takeaways
FIG. 28 Biotech API market, 2018 - 2030 (USD Billion)
FIG. 29 Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
FIG. 30 Monoclonal Antibodies market, 2018 - 2030 (USD Billion)
FIG. 31 Hormones market, 2018 - 2030 (USD Billion)
FIG. 32 Cytokines market, 2018 - 2030 (USD Billion)
FIG. 33 Recombinant Proteins market, 2018 - 2030 (USD Billion)
FIG. 34 Therapeutic Enzymes market, 2018 - 2030 (USD Billion)
FIG. 35 Vaccines market, 2018 - 2030 (USD Billion)
FIG. 36 Blood Factors market, 2018 - 2030 (USD Billion)
FIG. 37 Synthetic Europe API market, 2018 - 2030 (USD Billion)
FIG. 38 Europe API market: Type of manufacturers movement analysis
FIG. 39 Segment dashboard
FIG. 40 Europe API market Type of Manufacturers outlook: Key takeaways
FIG. 41 Captive Europe API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 42 Merchant Europe API market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 43 Europe API market: Type movement analysis
FIG. 44 Segment dashboard
FIG. 45 Europe API market type outlook: Key takeaways
FIG. 46 Generic APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 47 Innovative APIs market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 48 Europe API market: Type of Drug movement analysis
FIG. 49 Segment dashboard
FIG. 50 Europe API market type of drug outlook: Key takeaways
FIG. 51 Prescription market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 52 OTC market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 53 Europe API market: Application movement analysis
FIG. 54 Segment dashboard
FIG. 55 Europe API market application outlook: Key takeaways
FIG. 56 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 57 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 58 CNS & neurology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 59 Orthopedics market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 60 Endocrinology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 61 Pulmonology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 62 Gastroenterology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 63 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 64 Ophthalmology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 65 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 66 Regional outlook, 2021 & 2030
FIG. 67 Regional market dashboard
FIG. 68 Regional market place: Key takeaways
FIG. 69 Europe, SWOT Analysis
FIG. 70 Europe
FIG. 71 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 72 U.K.
FIG. 73 U.K. market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 74 Germany
FIG. 75 Germany market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 76 Spain
FIG. 77 Spain market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 78 France
FIG. 79 France market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 80 Italy
FIG. 81 Italy market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 82 Russia
FIG. 83 Russia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 84 Hungary
FIG. 85 Hungary market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 86 Poland
FIG. 87 Poland market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 88 Switzerland
FIG. 89 Switzerland market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 90 Portugal
FIG. 91 Portugal market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 92 Denmark
FIG. 93 Denmark market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 94 Sweden
FIG. 95 Sweden market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 96 Strategy Mapping